Sporulation is a complex cell differentiation programme shared by many members of the 22 Firmicutes, the end result of which is a highly resistant, metabolically inert spore that can 23 survive harsh environmental insults. Clostridium difficile spores are essential for transmission 24 of disease and are also required for recurrent infection. However, the molecular basis of 25 sporulation is poorly understood, despite parallels with the well-studied Bacillus subtilis 26 system. The spore envelope consists of multiple protective layers, one which is a specialised 27 layer of peptidoglycan, called the cortex, that is essential for the resistant properties of the 28 spore. We have identified and characterised a penicillin binding protein (PBP) that is required 29 for cortex synthesis in C. difficile. Surprisingly this PBP was also found to contribute to 30 cephalosporin resistance, indicating an additional role in the synthesis of vegetative cell wall. 31 This is the first description of a cortex-specific PBP in C. difficile and begins the process of 32 unravelling cortex biogenesis in this important pathogen. 33 34 35
Introduction RF20/RF311. The four DNA fragments were then joined in a Gibson assembly reaction. Sporulation efficiency analysis 146 Overnight cultures of C. difficile R20291 were diluted in BHI broth to an OD600nm of 0.01, 147 incubated for 8 h at 37°C, diluted to an OD600nm of 0.0001 and finally incubated overnight. This 148 allowed us to obtain cultures in stationary phase with no detectable spores (T=0). This culture 149 was then incubated for 5 days with vegetative cells and spores enumerated daily. For total 150 viable counts, 10-fold serial dilutions were spotted onto BHIS agar supplemented with 0.1% 151 sodium taurocholate. For total spore counts, the same process was carried out following a 30 152 min incubation at 65°C. Colonies were counted after 24 h incubation at 37°C and the assay was 153 completed in biological triplicates. Formation of phase bright spores was also followed by 154 phase-contrast microscopy at each time point. Samples fixed in 3.7% paraformaldehyde were 155 imaged using a Nikon Eclipse Ti microscope and analysed using Fiji (Schindelin et al., 2012) . imaged using a Nikon Ti Eclipse inverted microscope. Samples for transmission electron 161 microscopy were fixed as above before additional fixation in 3% glutaraldehyde, 0.1 M 162 cacodylate buffer. Fixed samples were then treated with 1% OsO4, dehydrated in ethanol and 7 embedded in araldite resin. Embedded samples were sectioned at 85 nm on a Leica UC6 164 ultramicrotome, transferred onto coated copper grids, further stained with uranyl acetate and 165 lead citrate and visualized using a FEI Tecnai BioTWIN TEM at 80 kV fitted with a Gatan 166 MS600CW camera. 167 For fluorescence confocal microscopy, bacteria were grown in TY broth containing 500 nM 168 HADA (Kuru et al., 2015) , labelled with 250 nM SNAP-Cell TMR-Star (New England 169 Biolabs) and grown under anaerobic conditions for a further 60 min. Following labelling, cells 170 were harvested at 8,000 x g for 2 min at 4°C and washed twice in 1 ml ice cold PBS. Cells 171 were resuspended in PBS and fixed in a 4% paraformaldehyde at room temperature for 30 min 172 with agitation. Cells were washed three times in 1 ml ice cold PBS, immobilized by drying to 173 a coverslip and mounted in SlowFade Diamond (Thermo Fisher Scientific (Oxoid) . The plates were dried at room temperature for 2 h and then pre-reduced in the 183 anaerobic cabinet for 2 h. 100 µl of each C. difficile strain at an OD600nm of 0.5 was spread onto 184 the plates. The plates were incubated for 48 h in the anaerobic cabinet at 37°C) and MICs were 185 determined by reading the lowest antibiotic concentration on which the bacteria did not grow.
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C. difficile produces a SpoVD homologue that is required for sporulation 189 The C. difficile R20291 genome encodes 10 putative penicillin binding proteins (PBPs) ( Table   190 2) and one predicted monofunctional transglycosylase (CDR20291_2283). In our previous 191 transposon mutagenesis study only two of these, CDR20291_0712 and 0985, were identified 192 as essential for growth in vitro (Dembek et al., 2015) . However, five of the PBPs were required 193 for formation of heat-resistant spores, including two with homology to the B. subtilis cortex 194 specific PBP SpoVD, CDR20291_1067 and 2544. Of these only CDR20291_2544 has the C 195 terminal PASTA domain that is characteristic of the B. subtilis sporulation-specific PBPs 196 (Bukowska-Faniband and Hederstedt, 2015) . CDR20291_2544 (SpoVDCd) shares 40.1% 197 amino acid identity with B. subtilis SpoVD and has the same predicted overall organisation, 198 with an N terminal predicted transmembrane helix, followed by a PBP dimerization domain 199 (PF03717), a transpeptidase domain (PF00905) and the C. terminal PASTA domain 200 (PF03793). spoVD is located immediately downstream of CDR20291_2545 ( Fig. 2A ), 201 encoding a protein with weak homology to B. subtilis FtsL (18.8% amino acid identity). 202 Despite the weak similarity, the C. difficile and B. subtilis proteins are very similar in size (115 203 and 117 amino acids respectively), have a similar PI (9.57 and 9.63 respectively) and both have 204 a high proportion of lysine residues (22.6% and 14.5% respectively). CDR20291_2545 and 205 spoVD appear to be in an operon, with the promoter upstream of CDR20291_2545. In our 206 earlier TraDIS screen, CDR20291_2545 was also found to be required for sporulation, 207 although this may have been due to polar effects on spoVD.
209
To confirm a role in sporulation, we constructed a clean spoVD deletion by homologous 210 recombination and then complemented this mutant by integrating the CDR20291_2545-spoVD 211 cassette under the control of the native promoter into the chromosome between the pyrE and 212 R20291_0189 genes (referred to here as R20291DspoVD pyrE::spoVD; Fig. 1A and B ). We 213 then analysed the ability of each strain to form heat-resistant spores. In our assay, a stationary 214 phase culture of wild type R20291 gradually accumulated spores, accounting for 81% of the 215 viable counts after 3 days ( Fig 1C) . In the same assay R20291DspoVD formed no detectable 216 spores, even after 5 days of incubation ( Fig 1D) . Complementation completely restored 217 sporulation to wild type levels ( Fig 1E) . Examination by phase contrast microscopy confirmed 218 the presence of abundant mature phase bright spores in 5 day old cultures of wild type R20291 219 and the complemented strain R20291DspoVD pyrE::spoVD ( Fig. 2A) . In contrast no phase 9 bright objects were observed in cultures of R20291DspoVD. When visualised at higher 221 magnification using TEM of thin sections, no morphologically normal spores were observed 222 in cultures of R20291DspoVD ( Fig. 2B ). Membrane-bound prespores were present, but these 223 structures were irregular in shape and crucially lacked the cortex and protein coat layers seen 224 in R20291 and the complemented strain developing spores. SpoVD is predicted to consist of 3 225 domains: a PBP dimerization domain, a transpeptidase domain and a PASTA domain (Fig. 226 3A). To identify which of these were required for viable spore formation, clip-spoVD was 227 placed under the control of a constitutive promoter (Pcwp2) in a C. difficile expression vector 228 and a panel of mutants, lacking one or more of these domains, were constructed (Table 1) . 229 These plasmids were all transferred into R20291DspoVD and the ability of the expressed spoVD had no effect on ciprofloxacin resistance (Table 3) . This mutation did however increase 268 susceptibility to cefoxitin and ceftazidime, decreasing the MIC 4-fold for each, with full 269 resistance restore upon complementation (R20291DspoVD pyrE::spoVD). To identify which 270 SpoVD domains were required for this resistance phenotype we complemented the DspoVD 271 mutant with the same panel of SpoVD truncations described above (Table 3) . Interestingly, 272 mutant SpoVDs that lacked either the PBP Dimerization (SpoVD(TP)) or the PASTA domains 273 (SpoVD(DT)) were still fully competent for restoring normal cephalosporin resistance, while 274 that lacking the Transpeptidase domain (SpoVD(DP)) displayed the same aberrant sensitivity 275 as the DspoVD mutant. This strongly suggests that only the Transpeptidase domain is required 276 for full cephalosporin resistance. To test if the Transpeptidase alone was sufficient for 277 resistance, we then constructed a truncation consisting of this domain alone. However, this 278 construct did not restore resistance to wild type levels. A full-length SpoVD with a single 279 amino acid substitution, replacing the putative nucleophilic serine with alanine 280 (SpoVD(S311A)), also failed to restore resistance, demonstrating that enzymatic activity is 281 required for the observed cephalosporin resistance. To test this latter possibility, we examined the peptidoglycan 329 composition of wild type and spoVD mutant cells but observed no obvious differences. Given 330 the enormous potential for redundancy with 10 encoded PBPs it is possible that small 331 differences could be missed in this analysis. To examine more subtle effects, we analysed 332 resistance to two PBP-targeting cephalosporin antibiotics, cefoxitin and ceftazidime. 333 Surprisingly the spoVD mutant displayed a 4-fold reduction in MIC to both antibiotics. 334 Although small, this difference in MIC was reproducible and complemented perfectly when 335 spoVD was added back. This unexpected observation strongly suggests that SpoVD is active 336 in vegetative cells and is not spore-specific as has been suggested for B. subtilis. 337 338 Sporulation of C. difficile represents one of the most pressing clinical challenges in tackling 339 recurrent disease in individual patients as well as preventing outbreaks in nosocomial settings. 340 However, this cell differentiation pathway also represents a promising target for the 341 development of C. difficile-specific therapeutics. In order to exploit this potential we must first 342 develop a deeper understanding of both the complex regulatory processes that underpin 343 sporulation as well as the function of the effector proteins that direct differentiation. Here we 344 have identified and characterised a PBP that is absolutely required for production of viable 345 spores and that we believe is a promising target for future therapeutics aimed at preventing 346 recurrent disease and transmission. 347 Stabler, R.A., He, M., Dawson, L., Martin, M., Valiente, E., Corton, C., et al. (2009). 473 Comparative genome and phenotypic analysis of Clostridium difficile 027 strains 474 provides insight into the evolution of a hypervirulent bacterium. Genome Biol 10(9), 475 R102. doi: 10.1186/gb-2009-10-9-r102. 476 Underwood, S., Guan, S., Vijayasubhash, V., Baines, S.D., Graham, L., Lewis, R.J., et al. 
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